his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
30 beneficiaries avail of services per minute
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The hospital hosted a two-day event with top internal and external faculty and medical experts
Subscribe To Our Newsletter & Stay Updated
